Retinoic acid (RA) regulates a wide range of biologic process, including inflammation. Previously, RA was shown to inhibit the clinical signs of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). The current study investigated the effects of 9-cis-RA on primary mouse microglia and astrocytes, two cell types implicated in the pathology of MS and EAE. The studies demonstrated that 9-cis-RA inhibited the production of nitric oxide (NO) as well as the pro-inflammatory cytokines TNF-a, IL-1h and IL-12 p40 by LPS-stimulated microglia. However, this retinoid had no effect on IL-6 secretion and increased MCP-1 production by LPS-stimulated microglia. In LPS-stimulated astrocytes, 9-cis-RA inhibited NO and TNF-a production but had not effect on IL-1h, IL-6 and MCP-1 secretion. These results suggest that RA modulates EAE, at least in part, by suppressing the production of NO and specific inflammatory cytokines from activated glia and suggests that RA might be effective in the treatment of MS. D
Introduction
Retinoids are vitamin A derivatives which play important roles in embryogenesis and, thereafter, for maintenance of functions such as vision, growth and reproduction (Zetterstrom et al., 1999) . Retinoic acid (RA) is an active metabolite of retinoids and regulates a wide range of biologic processes, including cell proliferation, differentiation, and morphogenesis (De Luca, 1991) . It is well known that RA modulates target cell activity by binding to specific nuclear receptors: retinoic acid receptors (RARa, h, g) and retinoid X receptors (RXRa, h, g). All-transretinoic acid (tRA) and 9-cis-retinoic acid (9-cis-RA) are natural derivatives of vitamin A. Although RARs bind and are activated by both the 9-cis-and the all-trans-isomers of retinoic acid, RXRs are exclusively activated by the 9-cis-isomer (Allenby et al., 1993; Heyman et al., 1992; Levin et al., 1992) .
RA has been shown to exert immunomodulatory and anti-inflammatory function in various cell types (Datta et al., 2001; Kim et al., 2004a,b; Mehta et al., 1994) . Recent studies suggest that inhibition of NF-kB translocation to the nucleus and suppression of JAK/STAT pathways may contribute to the anti-inflammatory mechanisms of RA (Choi et al., 2005; Dheen et al., 2005) . Since brain inflammation is a risk factor of neurodegenerative disease, the anti-inflammatory effect of RA may provide a novel therapeutic option for the treatment of neurodegenerative diseases, such as multiple sclerosis, Alzheimer's disease, Parkinson's disease and ischemic injury.
Several lines of evidence suggest that RA exerts beneficial effects on experimental autoimmune encephalomyelitis (EAE), which is an autoimmune disease characterized by central nervous system inflammation and demyelination, and represents an animal model of
